Claire McCaskill actually said...
As Ranking Member McCaskill noted in a recent report entitled, "Fueling an Epidemic: Insys Therapeutics and the Systemic Manipulation of Prior Authorization," Insys revenues tripled and profits rose 45 percent between 2013 and 2015.
04/18/2018